Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Katrina L. Lopez is active.

Publication


Featured researches published by Katrina L. Lopez.


Surgical Oncology-oxford | 2016

Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience.

Alberto A. Mendivil; Mark A. Rettenmaier; Lisa N. Abaid; John V. Brown; John P. Micha; Katrina L. Lopez; Bram H. Goldstein

BACKGROUND The purpose of this retrospective study was to assess the 5-year survival outcomes of cervical cancer patients who underwent an, open radical hysterectomy (ORH), robotic-assisted radical hysterectomy (RRH) or laparoscopic radical hysterectomy (LRH) for the treatment of their disease. METHOD We conducted a review of all cervical cancer patients who were managed with an ORH, RRH or LRH. RESULT Forty-nine patients were treated with LRH, 58 were managed via RRH and 39 patients underwent an ORH. The LRH (1.78 h) patients had a significantly shorter operative duration than the RRH (2.88 h) and ORH (2.39 h) subjects (p < 0.001). Blood loss was the highest in the ORH (475 cc) group (RRH = 207 cc and LRH = 312 cc) (P < 0.001). Moreover, the ORH (5.04 days) patients had a significantly longer hospital stay than the LRH (2.95 days) and RRH (2.50 day) subjects (P < 0.001). Kaplan-Meier survival analysis revealed a progression free survival (PFS) rate of 84.6% for the ORH group, 89.8% for the LRH group and 89.7% for the RRH patients (P = 0.271) at 60 months; overall survival was 92.3% for the ORH group, 95.9% for the LRH group and 96.6% for the RRH patients (P = 0.80). CONCLUSION The results from this study suggest that, irrespective of operative approach, patients who underwent a radical hysterectomy for early stage cervical cancer attained similar 5-year disease free and overall survival outcomes.


Journal of Surgical Oncology | 2010

Borderline ovarian tumors and extended patient follow-up: an individual institution's experience.

Mark A. Rettenmaier; Katrina L. Lopez; Lisa N. Abaid; John V. Brown; John P. Micha; Bram H. Goldstein

Borderline tumors of the ovary (BOT) comprise nearly 20% of all ovarian malignancies and are associated with a favorable prognosis. However, since these lesions can present with malignant features and recur, a further evaluation of appropriate patient management and long‐term follow‐up is warranted.


Oncology | 2011

Acute and delayed complications from surgery and adjuvant radiotherapy in the treatment of high-risk endometrial cancer.

Alberto A. Mendivil; Mark A. Rettenmaier; Craig Cox; Lisa N. Abaid; John V. Brown; John P. Micha; Katrina L. Lopez; Bram H. Goldstein

Objectives: This retrospective study assessed the number and type of complications following surgery and adjuvant radiotherapy in the treatment of high-risk endometrial cancer. Methods: Endometrial cancer patients who received surgery and postoperative radiotherapy (pelvic radiotherapy and/or vaginal brachytherapy) from April 1997 until October 2010 were evaluated. Short-term (≤6 months) and long-term (>6 months) complications (e.g., genitourinary/gastrointestinal complications) were comprehensively reviewed. Results: We identified 109 high-risk endometrial cancer patients who completed adjuvant radiotherapy following either a total abdominal hysterectomy (TAH; n = 53) or minimally invasive hysterectomy (MIS; n = 56). The combined impact of surgery and radiotherapy on complication type did not reach statistical significance (p > 0.05). However, surgery type and the development of a complication were significantly related (p < 0.001). The MIS patients developed complications at a more accelerated rate compared to the TAH patients (21 vs. 45 months), although the incidence of toxicity of grade 3 or 4 was much higher in the TAH group. Conclusions: The impact of MIS and adjuvant radiotherapy may have adversely affected the development of complications compared to TAH patients who received adjuvant radiotherapy, although higher-grade patient toxicity was more prevalent in the TAH group.


Surgical Innovation | 2017

A Prospective, Observational Trial Assessing the Efficacy of Abdominal Compression in Reducing Laparoscopic-Induced Shoulder Pain:

Mark A. Rettenmaier; John P. Micha; Katrina L. Lopez; Amber M. Wilcox; Bram H. Goldstein

Introduction: Postoperative shoulder pain is a condition associated with laparoscopic surgery and presumably attributed to residual carbon dioxide (CO2) in the abdomen. The intent of the current prospective, observational study was to assess the efficacy of abdominal compression in mitigating this painful complication. Methods: We recruited 30 patients who were treated with laparoscopic surgery for the management of gynecologic disease. All study participants underwent abdominal compression to evacuate the CO2 associated with their pneumoperitoneum. Postoperatively, the subjects’ pain intensity was measured via the visual analogue scale at 12, 24, and 48 hours. Results: The patients’ mean postoperative visual analogue scale pain scores were the highest during the initial 12 hours (1.93), and thereafter, steadily declined at 24 hours (0.73) and 48 hours (0.70) (P = .045). Furthermore, toxicity was reasonable, with only 20% of subjects who reported grade ≤2 nausea and vomiting. Conclusion: Abdominal compression is a relatively safe procedure that appears to sufficently evacuate residual CO2, thereby reducing the severity of laparoscopic surgery induced shoulder pain.


American Journal of Obstetrics and Gynecology | 2014

The retreatment of carboplatin via high-dose intraperitoneal chemotherapy in patients with a history of a hypersensitivity reaction

Mark A. Rettenmaier; Crystal M. Gray; Katrina L. Lopez; Karen A. Bechtol; Bram H. Goldstein

A hypersensitivity reaction attributed to platinum-based chemotherapy is a relatively common occurrence. Hyperthermic intraperitoneal chemotherapy potentially facilitates the safe retreatment of platinum therapy following this complication. We describe 3 ovarian cancer patients who were successfully retreated with carboplatin via hyperthermic intraperitoneal chemotherapy following hypersensitivity reaction.


International Journal of Surgery | 2015

Dramatically reduced incidence of vaginal cuff dehiscence in gynecologic patients undergoing endoscopic closure with barbed sutures: A retrospective cohort study

Mark A. Rettenmaier; Lisa N. Abaid; John V. Brown; Alberto A. Mendivil; Katrina L. Lopez; Bram H. Goldstein


Surgical Oncology-oxford | 2016

Lower-extremity lymphedema following management for endometrial and cervical cancer

Alberto A. Mendivil; Mark A. Rettenmaier; Lisa N. Abaid; John V. Brown; John P. Micha; Katrina L. Lopez; Bram H. Goldstein


Cancer Chemotherapy and Pharmacology | 2013

A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.

Lisa N. Abaid; John P. Micha; Mark A. Rettenmaier; John V. Brown; Alberto A. Mendivil; Katrina L. Lopez; Bram H. Goldstein


Archives of Gynecology and Obstetrics | 2011

The prognostic significance of optimal debulking in the setting of a complete clinical response for advanced ovarian carcinoma patients receiving maintenance chemotherapy

Lisa N. Abaid; Bram H. Goldstein; Katrina L. Lopez; John P. Micha; John V. Brown; Mark A. Rettenmaier; Maurie Markman


Cancer Chemotherapy and Pharmacology | 2017

Consolidation hyperthermic intraperitoneal chemotherapy for the treatment of advanced stage ovarian carcinoma: a 3 year experience

Alberto A. Mendivil; Mark A. Rettenmaier; Lisa N. Abaid; John V. Brown; Kristina Mori; Katrina L. Lopez; Bram H. Goldstein

Collaboration


Dive into the Katrina L. Lopez's collaboration.

Top Co-Authors

Avatar

Bram H. Goldstein

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Mark A. Rettenmaier

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

John V. Brown

Memorial Hospital of South Bend

View shared research outputs
Top Co-Authors

Avatar

Lisa N. Abaid

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Alberto A. Mendivil

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amber M. Wilcox

National Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Maurie Markman

Cancer Treatment Centers of America

View shared research outputs
Researchain Logo
Decentralizing Knowledge